104 results found.

Breast Cancer, or Neoplasm Metastasis Clinical Trial using Standard supportive care (packed RBC transfusion); epoetin alfa + packed RBC transfusion

Janssen Research & Development, LLC - Recruiting 18 years or older.
- A Randomized, Open-label, Multicenter, Phase 3 Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy.
Standard supportive care (packed RBC transfusion); epoetin alfa + packed RBC transfusion

Multiple Myeloma and Plasma Cell Neoplasm Clinical Trial using MV-NIS; cyclophosphamide; I-123 prior MV-NIS; I-123 post MV-NIS; Liothyronine

Mayo Clinic - Recruiting 18 years or older.
- Phase I Trial of Systemic Administration of Edmonston Strain of Measles Virus, Genetically Engineered to Express NIS, With or Without Cyclophosphamide, in Patients With Recurrent or Refractory Multiple Myeloma.
MV-NIS; cyclophosphamide; I-123 prior MV-NIS; I-123 post MV-NIS; Liothyronine

Neoplasm Malignant Clinical Trial using SAR245408; SAR245409

Sanofi - Recruiting N/A or older.
- International, Multicenter, Open-label, Treatment-extension Study for Subjects Who Completed a Phase 1 or Phase 2 Parental Study to Continue Receiving Treatment With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen.
SAR245408; SAR245409

Hematologic Disease, Hematologic Neoplasm, or Pancytopenia Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 2 years or older.
- Evaluation, Treatment and Training Protocol for Patients With Bone Marrow Failure States, Isolated or Multilineage Cytopenias, Metastatic Solid Tumors, or Hematologic Malignancies.

Glioblastoma Multiforme, Squamous Cell Carcinoma of Head and Neck Clinical Trial using CC-115

Celgene Corporation - Recruiting 18 years or older.
- A Phase 1a/b, Multicenter, Open Label, Dose-Finding Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the Dual DNA-PK and TOR Kinase Inhibitor, CC-115, Administered Orally to Subjects With Advanced Solid Tumors, and Hematologic Malignancies..
CC-115

Neuroendocrine Neoplasms, Thyroid Neoplasms, Parathyroid Neoplasm Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 7 years or older.
- Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms.

Myeloproliferative Neoplasms Clinical Trial using Ruxolitinib; Decitabine

Mount Sinai School of Medicine - Recruiting 18 years or older.
- Multicenter Phase I/II Trial of Ruxolitinib in Combination With Decitabine in Patients With Accelerated Phase Myeloproliferative Neoplasm (MPN) or Post-MPN AML.
Ruxolitinib; Decitabine

Malignant Neoplasm Clinical Trial using computer-assisted intervention; Standard educational information

Case Comprehensive Cancer Center - Recruiting 18 years or older.
- Tailoring Patient Education to Perceived Risk for Falls in Hospitalized Oncology Patients: A Pilot Study.
computer-assisted intervention; Standard educational information

Leukemia, Lymphoma, or Multiple Myeloma and Plasma Cell Neoplasm Clinical Trial using busulfan; cyclophosphamide; Stem cell infusion; Total body irradiation

Masonic Cancer Center, University of Minnesota - Recruiting N/A to 55 years.
- Unrelated or Partially Matched Allogeneic Donor Stem Cells for Lymphoma, Myeloma, and Chronic Lymphocytic Leukemia.
busulfan; cyclophosphamide; Stem cell infusion; Total body irradiation

Lung Neoplasm, or Cell Hypoxia Clinical Trial using 18F-FAZA; 18F-Fluorodeoxyglucose (18F-FDG)

AHS Cancer Control Alberta - Recruiting 18 years or older.
- A Study to See if a New Type of Imaging Can Help Our Understanding of the Course of Non-small Cell Lung Cancer in Patients Undergoing Treatment With Radiotherapy or Chemoradiotherapy.
18F-FAZA; 18F-Fluorodeoxyglucose (18F-FDG)

Malignant Neoplasm Clinical Trial using fluorine F 18 d-FMAU; positron emission tomography; computed tomography

University of Southern California - Recruiting 19 years or older.
- 18F-FMAU for Imaging in Cancer Patients.
fluorine F 18 d-FMAU; positron emission tomography; computed tomography

Pancreatic Cancer, Pancreatic Carcinoma Non-resectable, or Locall Clinical Trial using FOLFIRINOX; Algenpantucel-L Immunotherapy; 5-FU Chemoradiation; Gemcitabine; Capecitabine; Nab-Paclitaxel

NewLink Genetics Corporation - Recruiting 18 years or older.
- A Phase III Study of Chemotherapy With or Without Algenpantucel-L (HyperAcuter-Pancreas) Immunotherapy in Subjects With Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer.
FOLFIRINOX; Algenpantucel-L Immunotherapy; 5-FU Chemoradiation; Gemcitabine; Capecitabine; Nab-Paclitaxel

Hyperthyroidism, Hypothyroidism, or Pituitary Neoplasm Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Evaluation of Patients With Thyroid Function Disorders.

Stomach Neoplasm, Intestinal Neoplasm, or Rectal Neoplasm Clinical Trial using endoscopic sub-mucosal dissection

H“pital Edouard Herriot - Recruiting 18 years to 90 years.
- TRESTIS: Multicentric Study With a Curative Endoscopic Treatment of Superficial Neoplasia of a Digestive Tract by Endoscopic Submucosal Dissection: Evaluation of a New Water Jet System Injecting Glycerol Mix.
endoscopic sub-mucosal dissection

Hereditary Pancreatic Cancer, Intraductal Papillary Mucinous Neop Clinical Trial using dynamic contrast-enhanced magnetic resonance imaging

OHSU Knight Cancer Institute - Recruiting 18 years to 85 years.
- The Use of Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE MRI) in the Management of Pancreatic Cancer.
dynamic contrast-enhanced magnetic resonance imaging

Infection, Cancer, Neoplasm, Empyema, or Granuloma Clinical Trial using Xperguide CT; Electromagnetic Tracking; Computed Tomography

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Prospective Randomized Trial Comparing Navigation With Xperguide vs. Conventional Methods During Percutaneous Image Guided Procedures.
Xperguide CT; Electromagnetic Tracking; Computed Tomography

Adrenal Gland Neoplasm Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 3 years to 70 years.
- Clinical and Molecular Analysis of ACTH-Independent Steroid Hormone Production in Adrenocortical Tissue.

Hemangioblastoma, Hereditary Neoplastic Syndrome, Hippel Lindau D Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders.

Neoplasm Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 1 Month or older.
- Eligibility Screening and Tissue Procurement for the National Cancer Institute (NCI), Pediatric Oncology Branch (POB) Clinical Research Protocols.

Abnormalities, Craniopharyngioma, Cushing's Syndrome, Endocrine D Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 3 years to 70 years.
- A Clinical and Genetic Investigation of Pituitary Tumors and Related Hypothalmic Disorders.

Ewing's Sarcoma, Leukemia, Lymphoma, Neoplasm, or Sarcoma Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 3 Months to 40 years.
- Treatment of Children With Cancer.

Breast Cancer, Breast Neoplasm, Breast Tumor, or Cancer of the Br Clinical Trial using Proton Radiotherapy

Proton Collaborative Group - Recruiting 50 years or older.
- Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer.
Proton Radiotherapy

HIV Infection, or Neoplasm Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 7 years to 17 years.
- Psychological Benefits of a Normalized Camping Experience for Children With Cancer.

Thyroid Neoplasm Clinical Trial using Valproic Acid

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Origin.
Valproic Acid

Breast Cancer, Breast Neoplasm, Breast Tumor, or Cancer of the Br Clinical Trial using Proton Radiotherapy

Proton Collaborative Group - Recruiting 18 years or older.
- Phase II Study of Postoperative, Cardiac-Sparing Proton Radiotherapy for Women With Stage III,Loco-Regional, Non-Metastatic Breast Cancer.
Proton Radiotherapy

Neoplasm Malignant Clinical Trial using SAR566658

Sanofi - Recruiting 18 years or older.
- Dose Escalation, Safety and Pharmacokinetic, First in Man Study, of SAR566658 Administered as a Single Agent by Intravenous Infusion Every 3 Weeks in Adult Patients With CA6-Positive and Refractory Solid Tumors.
SAR566658

Vulvar Neoplasm Clinical Trial using Surgery, radiotherapy and chemotherapy; Surgery

Instituto do Cancer do Estado de Sao Paulo - Recruiting 18 years or older.
- New Strategy for the Treatment of Vulvar Cancer Employing Sentinel Scintigraphy, Surgery, Chemotherapy, and Radiotherapy.
Surgery, radiotherapy and chemotherapy; Surgery

Malignant Neoplasm Clinical Trial using music therapy; caregiver-related intervention or procedure; questionnaire administration; quality-of-life assessment

Children's Oncology Group - Recruiting 11 years to 24 years.
- Music Video for AYA-Parent Communication and Resilience.
music therapy; caregiver-related intervention or procedure; questionnaire administration; quality-of-life assessment

Neoplasm Metastases, or Hepatic Insufficiency Clinical Trial using Hepatic dysfunction group; Control group

Janssen Research & Development, LLC - Recruiting 18 years to 70 years.
- An Open-Label, Multicenter, Pharmacokinetic Study of Trabectedin in Subjects With Advanced Malignancies and Hepatic Dysfunction.
Hepatic dysfunction group; Control group

Neoplasm Malignant Clinical Trial using Cabazitaxel (XRP6258)

Sanofi - Recruiting 18 years or older.
- Phase I Safety and Pharmacokinetic Study of XRP6258 (Cabazitaxel) In Advanced Solid Tumor Patients With Varying Degrees of Hepatic Impairment.
Cabazitaxel (XRP6258)

Prostatic Neoplams, Prostate Cancer, Neoplasm, Prostate, or Neopl Clinical Trial using AMG 386; Abiraterone; Prednisone

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- A Phase II Multicenter Study of AMG 386 and Abiraterone in Metastatic Castration Resistant Prostate Cancer.
AMG 386; Abiraterone; Prednisone

Neoplasm of Mediastinal Lymph Nodes Clinical Trial

Centre hospitalier de l'Universit‚ de Montr‚al (CHUM) - Recruiting 18 years or older.
- Predicting Malignancy Using Endoluminal Ultrasound Characteristics in Mediastinal Lymph Nodes.

Breast Neoplasm, or Metastasis Clinical Trial using Eribulina

Medica Scientia Innovation Research - Recruiting 18 years or older.
- A Phase IIa Prospective, Multicenter, Open and Not Controlled of the Efficacy and Tolerability on the First Line Treatment With Eribulin as a Unic Agent on Patients With HER2 Negative Metastatic Breast Cancer Previously Treated With Taxanes.
Eribulina

Leukemia, Lymphoid Malignancies, or Metastatic Malignant Neoplasm Clinical Trial using Intrathecal Rituximab

M.D. Anderson Cancer Center - Recruiting 3 years or older.
- Safety and Efficacy of Intrathecal Rituximab in Patients With Lymphoid Malignancies Involving the Central Nervous System.
Intrathecal Rituximab

Colorectal Neoplasm Clinical Trial using Regorafenib (Stivarga, BAY 73-4506)

Bayer - Recruiting 18 years or older.
- RECORA- Regorafenib in Patients With Metastatic Colorectal Cancer (mCRC) After Failure of Standard Therapy.
Regorafenib (Stivarga, BAY 73-4506)

Anorexia, Cachexia, Malignant Neoplasm, or Oral Complications of Clinical Trial using bovine lactoferrin supplement; questionnaire administration; quality-of-life assessment; laboratory biomarker analysis

Comprehensive Cancer Center of Wake Forest University - Recruiting 18 years or older.
- A Pilot Study of Bovine Lactoferrin in Cancer Patients Reporting Taste Disturbances While Receiving Chemotherapy.
bovine lactoferrin supplement; questionnaire administration; quality-of-life assessment; laboratory biomarker analysis

Neoplasm Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 4 years or older.
- Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols.

Breast Neoplasm Clinical Trial

Medica Scientia Innovation Research - Recruiting 18 years or older.
- Observational, Retrospective and Multicenter Study to Evaluate the Clinical Benefit of Trastuzumab in Combination With Lapatinib in Metastatic Breast Cancer HER2 Positive Patients Who Has Been Previously Treated With Trastuzumab and/or Lapatinib.

Colorectal Cancer, Neoplasm Metastasis Clinical Trial using bevacizumab [Avastin]; 5-FU based doublet chemotherapy

Hoffmann-La Roche - Recruiting 18 years to 75 years.
- A Multi-center, Single-arm, Pilot Study of 5-FU Based Doublet Chemotherapy Plus Bevacizumab as Neoadjuvant Therapy for Patients With Previously Untreated Unresectable Liver-only Metastases From Colorectal Cancer.
bevacizumab [Avastin]; 5-FU based doublet chemotherapy

Malignant Neoplasm, or Psychosocial Effects of Cancer and Its Tre Clinical Trial using psychosocial assessment and care; educational intervention; communication skills training; questionnaire administration

City of Hope Medical Center - Recruiting 18 years to 30 years.
- Pilot Study of Psycho-Educational Group for Young Adults (YA) on Treatment: Impact on Knowledge, Distress, and Satisfaction.
psychosocial assessment and care; educational intervention; communication skills training; questionnaire administration

Neoplasm Malignant Clinical Trial using SAR405838; Pimasertib

Sanofi - Recruiting 18 years or older.
- A Phase 1 Study of Combination Therapy With SAR405838 and Pimasertib in Patients With Advanced Cancer.
SAR405838; Pimasertib

IPMN Clinical Trial

Asan Medical Center - Recruiting 20 years or older.
- Intraductal Papillary Mucinous Neoplasm (IPMN) With Malignant Change: Prospective Study to Assess Diagnostic Performance of CT and Magnetic Resonance Imaging (MR) According to International Consensus Guidelines 2012.

Cryptogenic Pyogenic Liver Abscess Clinical Trial

Inje University - Recruiting 18 years or older.
- The Prevalence of Colonic Neoplasm in Cryptogenic Pyogenic Liver Abscess.

Neoplasm Malignant Clinical Trial using SAR405838

Sanofi - Recruiting 18 years or older.
- A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Biological Activity of SAR405838 in Patients With Advanced Cancer.
SAR405838

Lymphedema, or Malignant Neoplasm Clinical Trial using recombinant human hyaluronidase; laboratory biomarker analysis; pharmacological study

Stanford University - Recruiting N/A or older.
- Pilot Phase I/II Investigational Study to Assess the Efficacy and Safety of Recombinant Hyaluronidase (rHUPH20) in the Treatment of Secondary Lymphedema Resulting From Local Management of Malignancy.
recombinant human hyaluronidase; laboratory biomarker analysis; pharmacological study

Neoplasms, Neoplasm Metastasis, or Lymphoma Clinical Trial using LY3039478

Eli Lilly and Company - Recruiting 18 years or older.
- A Phase 1 Study of LY3039478 in Patients With Advanced or Metastatic Cancer.
LY3039478

Neoplasms, Neoplasm Metastasis, Melanoma, Carcinoma, Non-Small-Ce Clinical Trial using LY3009120 capsule

Eli Lilly and Company - Recruiting 18 years or older.
- A Phase 1 Study of LY3009120 in Patients With Advanced or Metastatic Cancer.
LY3009120 capsule

Neoplasm Malignant Clinical Trial using SAR245409

Sanofi - Recruiting 18 years or older.
- A Phase 1 Dose-escalation Study of the Safety and Pharmacokinetics of a Tablet Formulation of SAR245409 Administered Daily to Patients With Solid Tumors or Lymphoma.
SAR245409

Breast Cancer, Cancer Survivor, Cognitive/Functional Effects, or Clinical Trial using cognitive intervention; questionnaire administration; quality-of-life assessment; blood-oxygen-level-dependent functional magnetic resonance imaging; memory intervention

University of Washington - Recruiting 21 years to 90 years.
- Behavioral and Neural Indices of Cognitive Rehabilitation in Women's Cancer: A Pilot Study..
cognitive intervention; questionnaire administration; quality-of-life assessment; blood-oxygen-level-dependent functional magnetic resonance imaging; memory intervention

Malignant Female Reproductive System Neoplasm Clinical Trial using Enoxaparin, Heparin

National Guard Health Affairs - Recruiting 18 years or older.
- A Randomized, Controlled, Open Label Study of the Efficacy and Safety of the Low Molecular Weight Heparin (LMWH), LovenoxTM (Enoxaparin) Versus HeparinTM (Unfractionated Heparin) for Prevention of Venous Thromboembolism (VTE) in Gynecologic Oncology Patients.
Enoxaparin, Heparin

Neoplasm Metastasis, Thyroid Neoplasm, or Thyroid Nodule Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Studies on Thyroid Nodules and Thyroid Cancer.

Acromegaly, or Pituitary Neoplasm Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Acromegaly Treatment and Natural History.

Brain Neoplasm, or Glioma Clinical Trial using IL13-PE38QQR

National Institutes of Health Clinical Center (CC) - Recruiting N/A to 17 years.
- An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-Grade Glioma.
IL13-PE38QQR

Cushing's Syndrome, Hereditary Neoplastic Syndrome, Lentigo, Neop Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 3 years or older.
- Definition of the Genotype and Clinical Phenotype of Primary Pigmented Nodular Adrenocortical Disease (PPNAD), Carney Complex, Peutz-Jeghers Syndrome and Related Conditions.

Neoplasm Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer or Normal Volunteers.

Neoplasm Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease.

Hyperparathyroidism, Hypocalcemia, Hypoparathyroidism, or Parathy Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Studies of Hyperparathyroidism and Related Disorders.

Malignant Solid Tumor - Malignant Nervous System Neoplasm Clinical Trial using Cabazitaxel (XRP6258)

Sanofi - Recruiting 2 years to 18 years.
- A Phase 1-2 Dose Finding, Safety and Efficacy Study of Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Tumors of the Central Nervous System.
Cabazitaxel (XRP6258)

Neoplasm Clinical Trial using PF-05212384; Docetaxel; Cisplatin; Dacomitinib

Pfizer - Recruiting 18 years or older.
- A Phase 1B Open-Label Three-Arm Multi-Center Study To Assess The Safety And Tolerability Of PF-05212384 (PI3K/MTor Inhibitor) In Combination With Other Anti-Tumor Agents.
PF-05212384; Docetaxel; Cisplatin; Dacomitinib

Carcinoma, Non-Small-Cell Lung, or Neoplasm Metastasis Clinical Trial using 34 Gy in a single fraction; 54Gy 18Gy/fr. x 3 fractions; 50Gy (12 x 5 fr.s); 60Gy (7.5Gy x 8fr.)

Institut Catal… d'Oncologia - Recruiting 18 years or older.
- Risk Adapted Free Flattering Filter Based Stereotactic Ablative Radiotherapy (Sabr) in Stage i Nsclc and Lung Metastases.
34 Gy in a single fraction; 54Gy 18Gy/fr. x 3 fractions; 50Gy (12 x 5 fr.s); 60Gy (7.5Gy x 8fr.)

Colostomy, Colorectal Neoplasm, or Diverticulitis Clinical Trial using Cruciate incision; Circular incision; Mesh enforced cruciate incision

Sahlgrenska University Hospital, Sweden - Recruiting N/A or older.
- Circular, Mesh Enforced or Cruciate Incision in the Abdominal Wall Fascia for coloStomy Construction - A Randomised Trial.
Cruciate incision; Circular incision; Mesh enforced cruciate incision

Multiple Myeloma and Plasma Cell Neoplasm Clinical Trial using bortezomib; dexamethasone

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Phase II Trial of Twice Weekly Induction Followed by Once Weekly IV Velcade (Bortezomib) With Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma Following at Least 1 Prior Therapy.
bortezomib; dexamethasone

Neoplasm Metastasis Clinical Trial using LY2940680

Eli Lilly and Company - Recruiting 20 years or older.
- A Phase 1 Study of LY2940680 in Japanese Patients With Advanced Solid Tumors.
LY2940680

Neoplasm Metastasis, or Lymphoma Clinical Trial using LY2835219

Eli Lilly and Company - Recruiting 20 years or older.
- A Phase 1 Study of LY2835219 in Japanese Patients With Advanced Cancer.
LY2835219

Malignant Neoplasm of Breast, CNS Malignancy, Malignant Neoplasm Clinical Trial using Alisertib; Pazopanib

University of Illinois at Chicago - Recruiting 18 years or older.
- Phase I Study of Aurora A Kinase Inhibitor (MLN8237) Given in Combination With Selective VEGFR Inhibitor Pazopanib (Votrient) for Therapy in Solid Tumors.
Alisertib; Pazopanib

Adult Spinal Cord Neoplasm, Recurrent Adult Spinal Cord Neoplasm, Clinical Trial using therapeutic conventional surgery; quality-of-life assessment

City of Hope Medical Center - Recruiting 18 years or older.
- Comparison of Minimally Invasive Approaches of Spine Tumor Surgery.
therapeutic conventional surgery; quality-of-life assessment

Adult Intracranial Neoplasm, or Vascular: Intracranial Clinical Trial using Fluorescein Sodium

Indiana University - Recruiting 18 years or older.
- Yellow 560 Microscope for Intraoperative Visualization of Fluorescein Stained Intracranial Lesions.
Fluorescein Sodium

Head and Neck Neoplasms, Neoplasm Metastasis, Recurrent Disease, Clinical Trial using BKM120

Centre Leon Berard - Recruiting 18 years or older.
- A Phase II, Multicenter Trial Aiming to Evaluate the Clinical Interest of a Monotherapy With BKM120 , a PI3K Inhibitor in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive Under Platin and Cetuximab-based Chemotherapy.
BKM120

Peutz-Jeghers Syndrome, Neoplastic Processes, or Neoplasm Metasta Clinical Trial using Everolimus

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) - Recruiting 18 years or older.
- Pilot Study of Everolimus in the Treatment of Neoplasms in Patients With Peutz-Jeghers Syndrome.
Everolimus

Malignant Neoplasm Clinical Trial using Total-body irradiation; Donor lymphocytes infusion (DLI); Cyclophosphamide; Allogeneic hematopoietic stem cell transplantation (HSCT); Tacrolimus; Mycophenolate mofetil

Thomas Jefferson University - Recruiting 18 years or older.
- A Two Step Approach to Haploidentical Hematopoietic Stem Cell Transplantation for Patients in Remission From HLA Partially-Matched Related Donors-Effect of Maternal Donors on Outcomes.
Total-body irradiation; Donor lymphocytes infusion (DLI); Cyclophosphamide; Allogeneic hematopoietic stem cell transplantation (HSCT); Tacrolimus; Mycophenolate mofetil

Physical Activity, Breast Neoplasm, Colorectal Neoplasm, or Gall Clinical Trial

Sahlgrenska University Hospital, Sweden - Recruiting 18 years or older.
- The Impact of Physical Activity on the Outcome of Surgery.

Childhood High-grade Cerebellar Astrocytoma, Childhood High-grade Clinical Trial using vorinostat; bevacizumab; temozolomide

National Cancer Institute (NCI) - Recruiting 3 years to 21 years.
- A Randomized Phase II/III Study of Vorinostat (IND# 71976) and Local Irradiation OR Temozolomide and Local Irradiation OR Bevacizumab (IND# 7921) and Local Irradiation Followed by Maintenance Bevacizumab and Temozolomide in Children With Newly Diagnosed High-Grade Gliomas.
vorinostat; bevacizumab; temozolomide

Stage IIIC Ovarian Cancer Clinical Trial using Laparoscopy; Cytoreduction

Catholic University of the Sacred Heart - Recruiting 18 years to 75 years.
- Surgical Complications Related to Primary or Interval Debulking in Ovarian Neoplasm.
Laparoscopy; Cytoreduction

Colon Cancer, Head and Neck Cancer, Lung Cancer, Lymphoma, Malign Clinical Trial using magnetic resonance imaging with positron emission tomography scanning

Case Comprehensive Cancer Center - Recruiting N/A or older.
- Evaluating Attenuation Correction Methods Applied to PET/MRI.
magnetic resonance imaging with positron emission tomography scanning

Secondary Malignant Neoplasm of Vertebral Column Clinical Trial

AOSpine International - Recruiting 18 years to 75 years.
- The Epidemiology, Process and Outcomes of Spine Oncology.

Brain Tumor, or Malignant Neoplasm of Fourth Ventricle of Brain Clinical Trial using Ommaya Reservoir; Methotrexate; Leucovorin

M.D. Anderson Cancer Center - Recruiting N/A to 22 years.
- Methotrexate Infusion Into the Fourth Ventricle in Children With Malignant Fourth Ventricular Brain Tumors: A Pilot Study.
Ommaya Reservoir; Methotrexate; Leucovorin

Colorectal Neoplasms Clinical Trial using Optimized ESD with snaring; Conventional ESD

Asan Medical Center - Recruiting 18 years or older.
- Comparison of Coventional Endoscopic Submucosal Dissection and Optimized Endoscopic Submucosal Dissection With Snaring for Colorectal Neoplasm.
Optimized ESD with snaring; Conventional ESD

Brain and Central Nervous System Tumors, Chronic Myeloproliferati Clinical Trial using 3'-deoxy-3'-[18F]fluorothymidine

Barbara Ann Karmanos Cancer Institute - Recruiting 18 years or older.
- Use of [F-18] FLT for Imaging With Positron Emission Tomography (PET).
3'-deoxy-3'-[18F]fluorothymidine

Neoplasm Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Evaluation of Late Effects and Natural History of Disease in Patients Treated With Radiotherapy.

Breast Cancer, Lung Cancer, Metastatic Cancer, Multiple Myeloma, Clinical Trial using assessment of therapy complications

Southwest Oncology Group - Recruiting N/A or older.
- S0702: A Prospective Observational Multicenter Cohort Study to Assess the Incidence of Osteonecrosis of the Jaw (ONJ) in Cancer Patients With Bone Metastases Starting Zoledronic Acid Treatment.
assessment of therapy complications

Multiple Myeloma and Plasma Cell Neoplasm Clinical Trial using clonality analysis; polymerase chain reaction; protein analysis; biologic sample preservation procedure; laboratory biomarker analysis; fluorescence spectroscopy; quality-of-life assessment

Boston Medical Center - Recruiting 18 years or older.
- Data, Tissue, Blood, and Urine Repository for Amyloid Diseases.
clonality analysis; polymerase chain reaction; protein analysis; biologic sample preservation procedure; laboratory biomarker analysis; fluorescence spectroscopy; quality-of-life assessment

Breast Cancer, or Locally Advanced Malignant Neoplasm Clinical Trial using Cholecalciferol; Inj. Progesterone; Doxyrubicin or Epirubicin

Tata Memorial Hospital - Recruiting 18 years to 70 years.
- Randomized Controlled Trial of Neo-adjuvant Progesterone and Vitamin D3 in Women With LOBC and LABC - A Feasibility Study.
Cholecalciferol; Inj. Progesterone; Doxyrubicin or Epirubicin

Secondary Malignant Neoplasm of Liver, or Colorectal Neoplasms Clinical Trial using Open liver resection; Laparoscopic liver resection

Oslo University Hospital - Recruiting 18 years or older.
- Prospective Randomized Study of Laparoscopic Versus Open Liver Resection for Colorectal Metastases.
Open liver resection; Laparoscopic liver resection

Esophageal Neoplasm, or Gastric Neoplasm Clinical Trial using Omegaven

University Hospitals, Leicester - Recruiting 18 years or older.
- Phase II Trial of Palliative Epirubicin, Oxaliplatin & Capecitabine (EOX) Chemotherapy Combined With Omega-3 Fish Oil Infusion (Omegaven) in Patients With Oesophagogastric Carcinoma.
Omegaven

Anemia, Hematologic Neoplasm, Neutropenia, Pancytopenia, or Throm Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 2 years or older.
- Screening Protocol for Subjects Being Evaluated for Hematology Branch Protocols.

Neoplasm Metastasis Clinical Trial using Biopsy; Blood samples; Pharmacokinetics; Midazolam clearance test

UMC Utrecht - Recruiting 18 years or older.
- Feasibility Study of Biomarker Development for Response Prediction by Large Scale DNA Mutational Analysis of Metastatic Lesions.
Biopsy; Blood samples; Pharmacokinetics; Midazolam clearance test

Rectal Neoplasm Clinical Trial using Hand-sewn coloanal anastomosis; Two staged Turnbull-Cutait procedure; Ultralow anterior rectal resection with total mesorectal excision

Hospital Universitari de Bellvitge - Recruiting 18 years to 74 years.
- Prospective Multicenter Randomized Controlled Trial Comparing Postoperative Complications and Quality of Life in Low Rectal Cancer Surgery Between Coloanal Anastomosis and Lateral Ileostomy Versus Two-Stage Turnbull-Cutait Coloanal Anastomosis.
Hand-sewn coloanal anastomosis; Two staged Turnbull-Cutait procedure; Ultralow anterior rectal resection with total mesorectal excision

Colorectal Neoplasms, Neoplasm Metastasis, or Liver Neoplasms Clinical Trial using Cetuximab; chemotherapy of mFOLFOX6 or FOLFIRI

Fudan University - Recruiting 18 years to 75 years.
- Study of Cetuximab in Combination With Chemotherapy for the First Treatment of Metastatic Colorectal Cancer.
Cetuximab; chemotherapy of mFOLFOX6 or FOLFIRI

Breast Neoplasm Clinical Trial using Tesetaxel once every 3 weeks; Tesetaxel once weekly

Genta Incorporated - Recruiting 18 years or older.
- A Phase II Study of Tesetaxel as First-line Therapy for Subjects With Metastatic Breast Cancer.
Tesetaxel once every 3 weeks; Tesetaxel once weekly

Breast Neoplasms, Endocrine Breast Diseases, or Neoplasm Metastas Clinical Trial using letrozole; lapatinib; everolimus

University of Maryland - Recruiting 18 years or older.
- GCC 0901- A Phase II Study of Letrozole in Combination With Lapatinib Followed by an Addition of Everolimus in Postmenopausal Women With Advanced Endocrine Resistant Breast Cancer.
letrozole; lapatinib; everolimus

Locally Advanced Malignant Neoplasm, Oral Cancer, or Oropharyngea Clinical Trial using Neo-adjuvant Erbitux-based chemotherapy

Shanghai Jiao Tong University School of Medicine - Recruiting 18 years to 75 years.
- Neo-adjuvant Erbitux-based Chemotherapy Followed by Surgery and Radiotherapy for Locally Advanced Oral/Oropharyngeal Cancer.
Neo-adjuvant Erbitux-based chemotherapy

Gastrointestinal Neoplasm, or Gastric Adenocarcinoma Clinical Trial using Irinotecan-Capecitabine-Oxaliplatin

AHS Cancer Control Alberta - Recruiting 18 years or older.
- A Multicentre, Open-label Phase II Study of Irinotecan, Capecitabine(Xeloda), and Oxaliplatin (IXO) as First Line Treatment in Patients With Metastatic Gastric or Gastroesophageal (GEJ) Adenocarcinoma..
Irinotecan-Capecitabine-Oxaliplatin

Dyskeratosis Congenita, Fanconi Anemia, Myelodysplastic Syndromes Clinical Trial using polymerase chain reaction; flow cytometry; immunologic technique; biopsy

University Hospital Freiburg - Recruiting N/A to 17 years.
- TCR Vbeta Repertoire and PNH Clones in Children With Refractory Cytopenia (RC). An Open Nonrandomised Multi-Center Prospective Study.
polymerase chain reaction; flow cytometry; immunologic technique; biopsy

Breast Cancer, or Neoplasm Metastasis Clinical Trial using Non pegylated liposomal doxorubicin, trastuzumab, docetaxel

Catharina Ziekenhuis Eindhoven - Recruiting 18 years or older.
- Phase II Multicentre Open Label Study Evaluating the Efficacy and Safety of Liposomal Doxorubicin, Trastuzumab, Docetaxel as First-line Treatment of Patients With HER2 Positive Metastatic Breast Cancer.
Non pegylated liposomal doxorubicin, trastuzumab, docetaxel

Endometrial Neoplasms, or Neoplasm Metastasis Clinical Trial using Tumor biopsy study

University of Bergen - Recruiting N/A or older.
- Prospective Study of Endometrial Cancer Treatment in Relation to Molecular Markers in Curettage Specimens..
Tumor biopsy study

Breast Neoplasms, or Neoplasm Metastasis Clinical Trial

Beijing Cancer Hospital - Recruiting 18 years to 75 years.
- Gene Expression Profiling of Metastatic Breast Cancer Predict the Therapeutic Response to Chemotherapy.

Renal Cell Carcinoma, Kidney Neoplasm, Renal Cancer, or Kidney Ca Clinical Trial using Yttrium-90 conjugated chimeric G250 (90Y-cG250)

Ludwig Institute for Cancer Research - Recruiting N/A or older.
- Cohort Study of Increasing Doses of Yttrium-90 Conjugated to Chimeric Monoclonal Antibody cG250 (90Y-DOTA-cG250) in Patients With Advanced Renal Cancer.
Yttrium-90 conjugated chimeric G250 (90Y-cG250)

GLIOBLASTOMA MULTIFORME, or Brain Neoplasm Clinical Trial

Washington University School of Medicine - Recruiting 18 years to 70 years.
- BIRN (Biomedical Informatics Research Network)Resources Facilitate the Personalization of Malignant Brain Tumor.

Breast Neoplasms, Neoplasm Metastasis, Gene Expression Profiling, Clinical Trial using cytokine

Beijing Cancer Hospital - Recruiting 18 years to 75 years.
- Gene Expression Profiling of Breast Cancer Cells in Pleural Effusion Prodict the Response of Malignant Pleural Effusion to Immunotherapy.
cytokine

Colorectal Neoplasm Clinical Trial using cap-assisted chromoendoscopy

Korean Association for the Study of Intestinal Diseases - Recruiting 45 years to 75 years.
- Prospective Randomized Controlled Trial of Cap-Assisted ChromoEndoscopy(CapACE) Versus Conventional Colonoscopy(CC) for the Detection and 3-year Recurrence Rate of Colorectal Neoplasia.
cap-assisted chromoendoscopy

Gastric Neoplasm Clinical Trial using Gastrectomy with more than D2 dissection; Neoadjuvant chemotherapy(TS-1+CDDP) followed by gastrectomy

Japan Clinical Oncology Group - Recruiting 20 years to 75 years.
- Randomized Phase III Trial of Surgery Plus Neoadjuvant TS-1 and Cisplatin Compared With Surgery Alone for Type 4 and Large Type 3 Gastric Cancer: Japan Clinical Oncology Group Study (JCOG 0501).
Gastrectomy with more than D2 dissection; Neoadjuvant chemotherapy(TS-1+CDDP) followed by gastrectomy

Brain Neoplasms, or Neoplasm Metastasis Clinical Trial using Whole brain radiation therapy arm; Salvage stereotactic radiosurgery arm

Japan Clinical Oncology Group - Recruiting 20 years to 79 years.
- Randomized Phase III Trial of Postoperative Whole Brain Radiation Therapy Compared With Salvage Stereotactic Radiosurgery in Patients With One to Four Brain Metastasis: Japan Clinical Oncology Group Study (JCOG 0504).
Whole brain radiation therapy arm; Salvage stereotactic radiosurgery arm

Multiple Myeloma and Plasma Cell Neoplasm Clinical Trial using bortezomib; hydroxychloroquine; immunologic technique; laboratory biomarker analysis; mass spectrometry; pharmacological study; biopsy

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Phase I/II Trial of Hydroxychloroquine Added to Bortezomib for Relapsed/Refractory Myeloma.
bortezomib; hydroxychloroquine; immunologic technique; laboratory biomarker analysis; mass spectrometry; pharmacological study; biopsy

Cognition, Fatigue, or Colorectal Neoplasm Clinical Trial using Neuropsychological Testing

University Health Network, Toronto - Recruiting 18 years to 75 years.
- Cognitive Function and Fatigue in Cancer Patients After Chemotherapy: A Longitudinal Controlled Study in Patients With Colorectal Cancer.
Neuropsychological Testing